Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
NEW YORK (Reuters Health) – A strategy that combines cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) provides acceptable long term survival for patients with pseudomyxoma peritonei of appendiceal…
NEW YORK (Reuters Health) – A second dose of quadrivalent meningococcal conjugate vaccine (MCV4) 6 months after the first dose significantly improves response rates in youth infected with…
NEW YORK (Reuters Health) – Implantation of a second transcatheter heart valve (THV-in-THV) is effective treatment for failed transcatheter aortic valve replacement (TAVR), according to a report in…
NEW YORK (Reuters Health) – Doxycycline treatment prompts amelioration of filarial lymphedema independent of active infection, researchers report in a May 18th on-line paper in Clinical Infectious Diseases.…
NEW YORK (Reuters Health) – Recombinant factor VIIa (rFVIIa) appears to be safe and effective when used for off-label indications in pediatric patients, according to a report from…
NEW YORK (Reuters Health) – Compared to white light cystoscopy, hexaminolevulinate fluorescence cystoscopic detection of papillary, nonmuscle invasive bladder cancer appears superior, researchers report in a May 12th…
Advanced medical imaging tests like CTs, MRIs and PET scans aid physicians in diagnosing many diseases earlier and more accurately. However, some of these tests result in radiation…
NEW YORK (Reuters Health) – Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a good first test in patients with isolated mediastinal lymphadenopathy (IML), one that might spare many…
NEW YORK (Reuters Health) – Infliximab for inflammatory bowel disease (IBD) is not associated with an increased risk for serious infection, death, or malignancy, including lymphoma, according to…
NEW YORK (Reuters Health) – The antiarrhythmic dronedarone (Multag, Sanofi SA) should be used with caution, particularly in patients with cardiovascular risk factors, advise clinicians in a report…
